AzTrials
AzTrials

AgingNCT05574634

The Role of the Locus Coeruleus in Age-related Distractibility

A study testing Tablet based adaptive multimodal attention practice program and Tablet based adaptive criterion task practice program in people with Aging and Alzheimer Disease, run by Virginia Polytechnic Institute and State University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

A growing body of research has highlighted the importance of frontal regions, at both the functional and structural levels, in age-related declines in attentional and cognitive processing. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Aging, Alzheimer Disease
What is being tested?
Tablet based adaptive multimodal attention practice program and Tablet based adaptive criterion task practice program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteUnited States
Study dates
11 Apr 2023to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy adult participants
  • No younger than 18 and no older than 75 yrs of age
  • Ability to provide written informed consent

Who cannot join

  • History of surgery involving metal implants
  • Possible metal fragments in the eyes
  • Pacemaker
  • A history of claustrophobia
  • Braces
  • Weighing over 250 pounds
Show all 9Show fewer
  • Pregnant or possibility of being pregnant.
  • Severe medical or psychiatric conditions (e.g., blind or deaf, head trauma)
  • Learning disabilities or developmental disabilities

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Tae-Ho Lee, PhD contact

540-231-6174

taehol@vt.edu

Benjamin Katz, PhD contact

540-231-9816

katzben@vt.edu

United States1 site, 1 recruiting
  • Virginia Polytechnic Institute and State University

    Blacksburg, Virginia, 24061

    Tae-Ho Lee, PhD, 540-231-6174, taehol@vt.edu

    Benjamin Katz, PhD, 540-231-9816, katzben@vt.edu

    Recruiting

Other trials in United States

About this study

Official title: Losing Specificity: the Role of the Locus Coeruleus in Age-related Distractibility

A growing body of research has highlighted the importance of frontal regions, at both the functional and structural levels, in age-related declines in attentional and cognitive processing. However, the underlying neurobiological pathophysiological changes in the brain that contribute to these declines are still largely unclear. The objective of this proposal is to investigate neural mechanisms of age-related attentional distractibility, focusing on the neural circuit initiated from the locus coeruleus (LC). In the current proposal, the investigators will test the hypothesis that the neural disconnectivity of LC with the salience network (SN) drives failures of ignoring distractors in older adults. The investigators will examine how LC-SN connectivity is associated with selective attention performance, and how improved LC-SN connectivity through a cognitive training program may lead to improved attentional performance.

Being tested
Tablet based adaptive multimodal attention practice program, Tablet based adaptive criterion task practice program
Medical subject headings
Alzheimer Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tablet based adaptive multimodal attention practice programBehavioural

    An adaptive at-home tablet-based program that includes variants of the Flanker Task, the Stroop Task, and a Visual Tracking Task. Each session of practice will include up to ten minutes with each of these task types, and the tasks will increase in difficulty in a way that further taxes attention (such as through more distractors or more incongruent trials) as participant performance improves.

  • Tablet based adaptive criterion task practice programBehavioural

    An adaptive, at-home tablet-based variant of the criterion task, that is, the selective attention/distraction task used during the scanning portion of the human participant portions of the study, that takes up to 25 minutes to complete each session.

Study groups in NCT05574634
Study groupRoleWhat they receive
Older adult participantsExperimentalOlder adult participants in the study will complete one of two variants of an attention practice program and that will be preceded by, and followed by, an fMRI scan session featuring an attention task
Receives: Behavioral: Tablet based adaptive multimodal attention practice program; Behavioral: Tablet based adaptive criterion task practice program
Younger adult participantsNo interventionYounger adult participants in the study will complete one fMRI scan session featuring an attention task

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in accuracy on the place-face selective attention task after two weeks

    During this task, participants will be presented to with target place stimuli overlaid on nonexpressive faces) and be asked to identify categories of place images ('building' to 'house') selectively as soon as possible while ignoring overlapped faces. The investigators will also include place only images to measure participants' baseline neural activation when there is no distractor. Each image condition will be presented in a mixed event related design that includes 15 blocks for each condition as a function of image type (overlaid vs. place-only). The block order will be counterbalanced and each block will be separated by a 10-s blank screen.

    Measured: Scan before and after attentional practice (2 weeks between scans)

  2. Change in fMRI LC-SN connectivity after two weeks

    An fMRI measure of LC-SN connectivity

    Measured: Scan before and after attentional practice (2 weeks between scans)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Oct 2022
  2. Study start11 Apr 2023
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05574634
Sponsor's protocol ID
19-514
Status last verified
Sep 2026
First submitted
13 Sep 2022
Last updated
14 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Tablet based adaptive multimodal attention practice program and Tablet based adaptive criterion task practice program in people with Aging and Alzheimer Disease, run by Virginia Polytechnic Institute and State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 14 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tae-Ho Lee, PhD (540-231-6174, taehol@vt.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in accuracy on the place-face selective attention task after two weeks (time frame: Scan before and after attentional practice (2 weeks between scans)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in